Heplisav

Dynavax: The Path Forward

Dynavax: The Path Forward

Seeking Alpha

Dynavax May Seek Quick Re-File of HepB Vax Following FDA Rejection

Dynavax May Seek Quick Re-File of HepB Vax Following FDA Rejection

TheStreet.com

Dynavax slides as FDA rejects adult hep B vaccine

Dynavax slides as FDA rejects adult hep B vaccine

Reuters

Dynavax Options Trade for Heplisav FDA Approval Decision

Dynavax Options Trade for Heplisav FDA Approval Decision

TheStreet.com

William Blair Analysts Are Gaining Comfort Ahead Of Dynavax's Heplisav PDUFA

William Blair Analysts Are Gaining Comfort Ahead Of Dynavax's Heplisav PDUFA

Seeking Alpha

Dynavax's Heplisav: Vaccinated Against Failure?

Dynavax's Heplisav: Vaccinated Against Failure?

Seeking Alpha

Why Dynavax's HEPLISAV Is Likely To Be Approved: Impact On Future Vaccine Development

Why Dynavax's HEPLISAV Is Likely To Be Approved: Impact On Future Vaccine Development

Seeking Alpha

Dynavax Shares Pummelled After FDA Panel

Dynavax Shares Pummelled After FDA Panel

Motley Fool

85% Probability Of FDA Approval For Dynavax's Heplisav, Says Cowen's Senior Analyst

85% Probability Of FDA Approval For Dynavax's Heplisav, Says Cowen's Senior Analyst

Seeking Alpha

3 Things to Watch With Dynavax

3 Things to Watch With Dynavax

Motley Fool